Literature DB >> 9524290

Analysis of serum cytokine levels in primary biliary cirrhosis patients and healthy adults.

M Yamashiki1, Y Kosaka, A Nishimura, S Watanabe, M Nomoto, F Ichida.   

Abstract

By using commercially available ELISA kits, serum IL-6 and TNF-alpha levels in healthy adults, and the levels of various cytokines in patients with primary biliary cirrhosis or chronic viral liver diseases, were investigated. IL-6 levels of healthy subjects were distributed in a wide range, and the distribution pattern was similar to those of the patients. TNF-alpha levels tended to be low in females in their 30s, but there were no abnormalities in the patients. Characteristic findings, in the primary biliary cirrhosis patients, were an increase of IFN-gamma and IL-2 levels, and a decrease of GM-CSF levels (P < 0.05). IL-8 levels were higher in the patients than in the healthy subjects (P < 0.05), and the increase was remarkable in chronic viral liver disease patients. We believe that measurement of serum cytokine levels as a clinical immunological test is highly useful. Further development of simpler, more rapid, and more sensitive analysis methods is desired.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9524290      PMCID: PMC6807844     

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  14 in total

1.  An enzyme-linked immunosorbent assay for the measurement of human interleukin-6.

Authors:  N Ida; S Sakurai; T Hosaka; K Hosoi; T Kunitomo; Y Matsuura; M Kohase
Journal:  J Immunol Methods       Date:  1990-10-19       Impact factor: 2.303

2.  Two-color analysis of peripheral lymphocyte surface antigens in inherently healthy adults.

Authors:  M Yamashiki; A Nishimura; Y Kosaka; S P James
Journal:  J Clin Lab Anal       Date:  1994       Impact factor: 2.352

3.  Serum levels of cytokines in chronic liver diseases.

Authors:  H Tilg; A Wilmer; W Vogel; M Herold; B Nölchen; G Judmaier; C Huber
Journal:  Gastroenterology       Date:  1992-07       Impact factor: 22.682

4.  Herbal medicine 'Sho-saiko-to' induces tumour necrosis factor-alpha and granulocyte colony-stimulating factor in vitro in peripheral blood mononuclear cells of patients with hepatocellular carcinoma.

Authors:  M Yamashiki; A Nishimura; M Nomoto; H Suzuki; Y Kosaka
Journal:  J Gastroenterol Hepatol       Date:  1996-02       Impact factor: 4.029

5.  Analysis of the in vitro cytokine production by liver-infiltrating T cells of patients with autoimmune hepatitis.

Authors:  J F Schlaak; H Löhr; H Gallati; K H Meyer zum Büschenfelde; B Fleischer
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

6.  Increased plasma interleukin-8 concentrations in alcoholic hepatitis.

Authors:  D B Hill; L S Marsano; C J McClain
Journal:  Hepatology       Date:  1993-09       Impact factor: 17.425

7.  Elevated serum interleukin-6 levels in patients with acute hepatitis.

Authors:  Y Sun; K Tokushige; E Isono; K Yamauchi; H Obata
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

8.  Efficacy of a herbal medicine "sho-saiko-to" on the improvement of impaired cytokine production of peripheral blood mononuclear cells in patients with chronic viral hepatitis.

Authors:  M Yamashiki; Y Kosaka; A Nishimura; K Takase; F Ichida
Journal:  J Clin Lab Immunol       Date:  1992

9.  Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure.

Authors:  Y Muto; K T Nouri-Aria; A Meager; G J Alexander; A L Eddleston; R Williams
Journal:  Lancet       Date:  1988-07-09       Impact factor: 79.321

10.  Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon.

Authors:  M J Skoskiewicz; R B Colvin; E E Schneeberger; P S Russell
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

View more
  7 in total

1.  Semi-quantitative analysis of cytokine mRNA expression induced by the herbal medicine Sho-saiko-to (TJ-9) using a Gel Doc system.

Authors:  X X Huang; M Yamashiki; K Nakatani; T Nobori; A Mase
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  CD4+ CD25+ but not CD4+ Foxp3+ T cells as a regulatory subset in primary biliary cirrhosis.

Authors:  Dandan Wang; Huayong Zhang; Jun Liang; Zhifeng Gu; Qiang Zhou; Xiangshan Fan; Yayi Hou; Lingyun Sun
Journal:  Cell Mol Immunol       Date:  2010-08-23       Impact factor: 11.530

3.  Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis.

Authors:  Tamara N Pereira; Meagan J Walsh; Peter J Lewindon; Grant A Ramm
Journal:  World J Gastrointest Pathophysiol       Date:  2010-06-15

4.  Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis.

Authors:  Katryn Allen; Hartmut Jaeschke; Bryan L Copple
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

5.  Upregulation of early growth response factor-1 by bile acids requires mitogen-activated protein kinase signaling.

Authors:  Katryn Allen; Nam Deuk Kim; Jeon-Ok Moon; Bryan L Copple
Journal:  Toxicol Appl Pharmacol       Date:  2009-11-17       Impact factor: 4.219

6.  A Mouse Model of Autoimmune Cholangitis via Syngeneic Bile Duct Protein Immunization.

Authors:  Wen-Tao Ma; Qing-Zhi Liu; Jing-Bo Yang; Yan-Qing Yang; Zhi-Bin Zhao; Hong-Di Ma; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Sci Rep       Date:  2017-11-10       Impact factor: 4.379

7.  ABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population.

Authors:  Edward J Andress; Michael Nicolaou; Farrell McGeoghan; Kenneth J Linton
Journal:  Cell Mol Life Sci       Date:  2017-02-20       Impact factor: 9.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.